Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Pharmacielo Ltd V.PCLO

Alternate Symbol(s):  PCLOF

Financial Services Healthcare Asset Management
PharmaCielo Ltd. is a Canada-based company with a focus on ethical and sustainable processing and supplying of all natural, pharmaceutical-grade medical cannabis products to channel distributors. The Company has two subsidiaries, PharmaCielo Colombia Holdings S.A.S. (PharmaCielo Colombia) and Ubiquo Telemedicina S.A.S. (Ubiquo). PharmaCielo Colombia cultivates and processes the Company’s all... see more

Recent & Breaking News (TSXV:PCLO)

PharmaCielo Signs Binding Letter of Intent to Acquire Operations in Thailand; Announces $2 Million Non-Brokered Private Placement with Participation from PharmaCielo Insiders and Siam Ventures Investors

Newsfile 13 days ago

PharmaCielo to Supply Ease Labs with Commercial Shipments of API to Fulfill Contract with State Government of Sao Paulo, Brazil

Newsfile March 26, 2024

Colombian Government Continues its Support of Domestic Cannabis Industry - Resolution Extending THC Inventory Allowance Provides Immediate Benefit to PharmaCielo

Newsfile March 1, 2024

Benuvia and PharmaCielo Announce Strategic Partnership to Manufacture cGMP Pharmaceutical-Grade CBD Isolate and Related Products

Newsfile January 4, 2024

PharmaCielo Announces Q3 2023 Financial Results

Newsfile November 29, 2023

PharmaCielo Raises $3.3 Million Under Previously Announced Non-Brokered Private Placement

Newsfile October 6, 2023

PharmaCielo Announces Q2 2023 Financial Results

Newsfile August 29, 2023

PharmaCielo Provides Corporate Update

Newsfile August 10, 2023

PharmaCielo Announces Appointment of Marc Lustig as Chairman and CEO

Newsfile July 11, 2023

PharmaCielo Provides Corporate Update

Newsfile June 29, 2023

PharmaCielo Announces Q1 2023 Financial Results

Newsfile May 29, 2023

PharmaCielo (TSXV:PCLO) to ship pharmaceutical grade cannabis extract to South Africa

Jonathon Brown May 16, 2023

PharmaCielo Announces Shipment of Pharmaceutical Grade Cannabis Extract to Customer in South Africa

Newsfile May 16, 2023

PharmaCielo Announces Financial Results for the Fourth Quarter and Fiscal Year Ended December 31, 2022

Newsfile May 1, 2023

PharmaCielo (TSXV:PCLO) partners with CANNPRISMA to expand in the European market

Shoran Devi April 19, 2023

PharmaCielo Announces Strategic Partnership with CANNPRISMA to Supply EU-GMP Certified Dried Flower to the European Medicinal Cannabis Market

Newsfile April 19, 2023

PharmaCielo Receives Purchase Order for API from Brazilian Pharmaceutical Company - Represents Third Customer in the Country

Canada NewsWire February 8, 2023

PharmaCielo Announces Continued Progress on Efficiency Initiatives to Accelerate Profitability and Intention to Amend Warrant Terms

Canada NewsWire February 2, 2023

PharmaCielo Receives First Commercial Purchase Order from Ease Labs Pharma - Proprietary API a Key Ingredient in Recently Approved Product for Brazilian Market

Canada NewsWire January 30, 2023

PharmaCielo Announces First Shipment of Pharmaceutical Grade Cannabis Extract to Customer in Morocco

Canada NewsWire December 5, 2022